Drugs Take Backseat to Seeds at Bayer With Monsanto Acquisition – Bloomberg

Drugs Take Backseat to Seeds at Bayer With Monsanto Acquisition
Bloomberg
In the wake of its $66 billion-acquisition of Monsanto Co., Bayer AG risks starving its lucrative drugs business of the resources it needs to grow. Funded with a combination of debt and equity, the deal announced Wednesday will transform Bayer into the …
Bayer Secures Monsanto Takeover With $56 Billion BidNew York Times
Monsanto Deal Creates Farm Giant — WSJNasdaq
Bayer's Monsanto acquisition to face politically charged scrutinyReuters
Washington Post –STLtoday.com –Fortune –Wall Street Journal (blog)
all 507 news articles »